Research Article
[Retracted] Free Triiodothyronine Is Independently Associated with Nonalcoholic Fatty Liver Disease in Hospitalized Type 2 Diabetes Mellitus Patients
Table 2
Biochemical indicators of hospitalized type 2 diabetes patients with or without NAFLD.
| | Variable | No NAFLD () | NAFLD () | Statistics () | |
| | FINS (pmol/L) | 53.93 (60.53) | 73.91 (38.51) | -5.14 | <0.001 | | FCP (nmol/L) | 0.54 (0.63) | 0.70 (0.47) | -7.17 | <0.001 | | 1h-CP (nmol/L) | 1.07 (1.03) | 1.33 (1.43) | -6.54 | <0.001 | | 2h-CP (nmol/L) | 1.17 (1.23) | 1.43 (1.87) | -5.76 | <0.001 | | HbA1c (%) | 8.70 (4.10) | 8.30 (3.30) | -1.14 | 0.26 | | ABG (mmol/L) | 12.70 (6.30) | 12.10 (9.90) | -2.45 | <0.001 | | FBG (mmol/L) | 7.09 (3.46) | 7.56 (4.28) | -2.22 | <0.05 | | 1hBG (mmol/L) | 12.09 (4.07) | 12.36 (4.48) | -4.38 | <0.001 | | 2hBG (mmol/L) | 10.99 (5.62) | 11.15 (4.80) | -3.38 | <0.001 | | HOMA-IR | 21.13 (24.05) | 23.65 (14.29) | -4.99 | <0.001 | | HOMA-β | 294.88 (298.76) | 257.52 (400.81) | -2.21 | <0.05 | | TSH (mU/L) | 1.77 (1.31) | 1.60 (1.53) | -0.44 | 0.66 | | FT3 (pmol/L) | 4.32 (0.89) | 4.39 (0.58) | -4.07 | <0.001 | | FT4 (pmol/L) | 15.29 (3.03) | 16.18 (3.35) | -0.76 | 0.45 | | ALT (U/L) | 19.00 (15.20) | 30.00 (22.00) | -6.87 | <0.001 | | AST (U/L) | 19.00 (10.00) | 23.00 (10.50) | -3.84 | <0.001 | | GGT (U/L) | 24.00 (28.00) | 33.00 (30.00) | -7.18 | <0.001 | | UN (mmol/L) | 4.78 (2.15) | 4.64 (2.28) | -4.01 | <0.001 | | CR (μmol/L) | 69.00 (39.00) | 75.00 (39.00) | -2.33 | <0.05 | | UA (μmol/L) | 342.00 (137.00) | 372.00 (177.00) | -3.26 | <0.001 | | TC (mmol/L) | 1.72 (1.76) | 2.12 (2.39) | -8.48 | <0.001 | | TG (mmol/L) | 4.33 (1.47) | 4.68 (1.36) | -3.00 | <0.01 | | HDL-C (mmol/L) | 1.16 (0.39) | 1.16 (0.29) | -1.10 | 0.27 | | LDL-C (mmol/L) | 2.51 (1.01) | 2.69 (1.02) | -1.33 | 0.18 | | 24h-UTP (g/24 h) | 91.60 (118.70) | 82.20 (107.50) | -0.20 | 0.85 | | 24hU-ABL (mg/24 h) | 17.94 (47.43) | 19.68 (22.59) | -0.84 | 0.4 | | 24hU-ALB/CR (%) | 18.31 (34.22) | 15.43 (19.08) | -0.64 | 0.52 | | GFR (mL min-1 1.73 m-2) | 92.29 (49.98) | 109.53 (53.11) | 2.36 | <0.05 | | DDi (ng/mL) | 0.24 (0.26) | 0.15 (0.22) | -5.21 | <0.001 | | CRP (mg/L) | 0.90 (4.50) | 0.80 (4.20) | -1.42 | 0.16 | | HCY (μmol/L) | 10.10 (3.10) | 10.90 (5.60) | -0.36 | 0.72 |
|
|
FINS: fasting insulin; FCP: fasting C peptide; ABG: admission blood glucose; FBG: fasting blood glucose; HbA1c: glycated hemoglobin; TSH: thyroid-stimulating hormone; FT3: free triiodothyronine; FT4: free four iodothyronine; ALT: alanine transferase; AST: aspartate aminotransferase; GGT: glutamyl transpeptidase; UN: urea nitrogen; CR: creatinine; UA: uric acid; TG: triglycerides; TC: total cholesterol; HDL: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; 24h-UTP: 24-hour urine protein quantification; 24hU-ABL: 24-hour urine albumin quantification; 24hU-ALB/CR: 24-hour urine albumin quantification to creatinine ratio; GFR: glomerular filtration rate; DDi: D-dimer; CRP: C-reactive protein; HCY: homocysteine; 1hBG: 1 h blood glucose; 1hINS: 1 h insulin; 1h-CP: 1 h C peptide; 2hBG: 2 h blood glucose; 2hINS: 2 h insulin; 2h-CP: 2 h C peptide; HOMA-IR: homeostasis model assessment-insulin resistance; HOMA-β: homeostasis model assessment-β.
|
